Search Orphan Drug Designations and Approvals
-
Generic Name: | Erythropoietin (recombinant human) |
---|---|
Date Designated: | 08/19/1987 |
Orphan Designation: | Treatment of anemia associated with end stage renal disease. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
McDonnell Douglas Corp P.O. Box 516, 107/2 MS10 St. Louis, Missouri 63166 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-